Welcome to Critical MassLaw.com’s weekly digest for class action and mass tort attorneys. Here’s what’s happening: Why did the DOJ file notices in four class actions over “no poach” agreements? A judge in the Facebook/Cambridge Analytica case has a long chat with the lawyers. Find out which firm won a $41 million pelvic mesh verdict last week.

Send your feedback to abronstad@alm.com, or find me on Twitter: @abronstadlaw.

 

 

DOJ Encroaches on ‘No Poach’ Class Actions

Class actions have proliferated against restaurant franchises since the U.S. Department of Justice’s antitrust division issued guidance on so-called “no poach” agreements in 2016. In class actions filed in the wake of that guidance, a handful of judges have issued rulings against companies like McDonald’s and Cinnabon. Now, the DOJ has something to say in cases challenging “no-poach” provisions, according to my story about notices the government has filed in at least four cases.

I asked two defense lawyers what the DOJ’s moves could mean. Andrea Murino(Goodwin) told me:

“It’s clear they have concerns the guidance is being used in too sweeping a fashion, and so they’re trying to carve some limits around it.”

Not necessarily, said Tara Reinhart (Skadden). As to the cases involving franchises, which plausibly could argue that “no-poach agreements” help them compete with other brands, she told me: “The DOJ is actually getting into these cases not to clarify its own 2016 statement but to make sure that franchise agreements are evaluated consistently, as they have been over the years.”

But in a case involving two railroad equipment suppliers, which the DOJ sued last year, the goal might be different. Reinhart told me:

“The defendants are taking the position that no-poach agreements, as a general proposition, should be treated under rule of reason and not per se, and there is really a lack of developed case law on this question. The DOJ is saying no-poach agreements are per se unlawful unless they’re necessary to a legitimate collaboration. They’re making an affirmative point, and that’s also the point of their original 2016 guidance.”

 

 

Facebook Friends … or Foes?

Did Facebook’s users consent to having the social media site hand over their personal data to political consulting firm Cambridge Analytica? That’s the question U.S. District Judge Vince Chhabria grappled with last week at the first hearing on Facebook’s motion to dismiss class actions brought over the scandal, according to my colleague Ross Todd’s story.

The judge told lawyers that Facebook’s handling of the matter “was at the minimum providing terrible service to its customers.” But he couldn’t say whether the plaintiffs had a viable claim. Ross told me that Chhabria ordered the plaintiffs to file an amended complaint within 21 days to address his concerns:

“Namely, he wants to know about individual plaintiffs’ Facebook experiences. He wants allegations about what the default settings were at different times during the class period. Was the default for user information to be public or was it ‘Friends Only’? And he indicated that though Facebook did seem to disclose that third parties could access a Facebook user’s information via their friends’ use of a Facebook-connected app, those disclosures might have been inadequate given the sensitivity of the information that those third parties had access to.”

 

 

Mesh Maker Hit With $41 Million Verdict

A Philadelphia jury awarded $41 million to a woman who had nine surgeries stemming from her transvaginal mesh device made by Johnson & Johnson’s Ethicon Inc. Representing the plaintiff were Thomas Kline and Kila Baldwin, both of Kline & Specter. Ethicon’s defense team was Tarek Ismail (Goldman Ismail), Anita Modak-Truran (Butler Snow), and Joseph O’Neil (Campbell Conroy & O’Neil). Interesting side note: Kline & Specter partner Shanin Specter objected to a 5% holdback in common benefit fees in the federal pelvic mesh cases, in part because of what he called “puny settlements” when compared to the verdicts he’s gotten. U.S. District Judge Joseph Goodwin rejected that argument last week, awarding a potential $550 million in fees.


Here’s what else you need to know:

Talc Time-Out: The Missouri Supreme Court has halted another trial linking Johnson & Johnson talcum powder products to ovarian cancer. The Jan. 31 order granted a petition filed by Imerys Talc America (a J&J talc supplier) for a writ of prohibition, effectively postponing an April 8 trial testing claims on behalf of 24 women. Last month, the Missouri Supreme Court granted a similar petition by Johnson & Johnson over a planned Jan. 22 trial involving 13 women. The issue is whether there’s enough of a connection to Missouri in light of the U.S. Supreme Court’s Bristol-Myers Squibb Co. v. Superior Court decision in 2017.

Chamber SupportChief legal officers and general counsel from 30 U.S. corporations, including BayerBPFord and Johnson & Johnson, last week signed onto a letter backing a proposal to amend the Administrative Office of U.S. Courts’ Committee on Rules of Practice and Procedure to require disclosure of third-party litigation financing in civil actions. The U.S. Chamber of Commerce’s Institute for Legal Reform pushed for such amendments in 2017.

Home Turf: Remember last month’s oral arguments before the U.S. Supreme Court in Home Depot v. Jackson? That’s the case about whether a third-party counterclaim defendant can remove a case to federal court under the U.S. Class Action Fairness ActLaw.com has a profile of Home Depot’s lawyer in the case–Will Barnette, the home-improvement retailer’s in-house associate general counsel. Barnette got the rare opportunity to argue the case before the U.S. Supreme Court. The plaintiffs’ attorney was F. Paul Bland of Public Justice. “I don’t think I’ve ever been that prepared for anything else,” Barnette said in the story. “I was nervous but less nervous than I expected I would be. I felt focused from the beginning and made the arguments I wanted to make.”

Thanks for reading Critical Mass. See you next week!